Novotech Backs GoGive1 Vaccine Campaign

Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific region, with more than 2,000 staff globally, has joined the GoGive1 campaign, where for every fully vaccinated team member a vaccine is donated to a person in a lower income country.

A recent company-wide survey showed 95% of team members have had at least 1 dose or plan to be vaccinated. 

Novotech joined the GoGive1 campaign, backed by the WHO Foundation and GAVI, as part of the company’s COVID-19 safe workplace initiative.

The Novotech workplace policy requires team members who work in the office, visit sites or travel to provide evidence that they have been fully vaccinated. 

Novotech CEO John Moller said:

“Providing a safe working environment for staff is a priority for all employers around the world, and at Novotech we have an additional duty to protect the healthcare workers and patients at the sites we visit.

Our COVID-19 vaccination policy supports our objective of reaching full vaccination across the company.  

Our approach considers local vaccine availability and rollout, and we are funding vaccinations for Team Members where there is limited government support or to accelerate the vaccination process. 

As part of this program, Novotech is donating one vaccine for every fully vaccinated team member, to a lower income country via the WHO and GAVI GoGive1 initiative.”

Novotech’s Chief People Officer, Angela Edwardson said:

“Since vaccines have become available, we have strongly encouraged our Team Members to get vaccinated. 

We have overwhelming support for our company policy that employees should be fully vaccinated on their return to the office. Meanwhile our flexible work options will also allow unvaccinated employees to work remotely as we transition. 

We look forward to welcoming teams back to the office as restrictions ease across our regions.” 

Our key initiatives

  • Novotech is funding vaccination for team members in countries that have limited government support, or to accelerate the vaccination process. 
  • Team members who work in the office, visit sites or travel will need to provide evidence that they have been fully vaccinated or have received a negative test result. 
  • Policy implementation will be phased and dependent on vaccine rollout and availability in each location 
  • Novotech’s flexible working options facilitate Team Members to receive their vaccinations during normal working hours 

Novotech’s vaccine donation and matching programs

 Novotech Backs GoGive1 Vaccine Campaign as Part of Company-wide COVID Safe Workplace Initiative

 

Go Give 1 incentive program 

https://gogiveone.org/

For every fully vaccinated team member, Novotech will donate 1 Vaccine via the GoGive1 program. GoGive1 was created by the WHO Foundation and GAVI (https://www.gavi.org/gavi-covax-amc). Novotech has the potential to contribute over 2,000 vaccinations via this program

Donation Matching Program 

In May 2021, Novotech ran a donation matching initiative, matching all employee donations to Care.org, to provide urgent funding to India during the peak of their COVID-19 outbreak.

Media contact

Novotech(Novotech-CRO.com) 소개

1997년에 설립된 노보텍(Novotech)은 글로벌 full-Service CRO이자 임상과학 자문 기업으로, 바이오텍 및 제약회사의 보다 체계적이고 성공적인 시장 진입을 지원합니다. 아시아 태평양, 북미, 유럽 전역에 걸쳐 30개 이상의 지사와 5,000개 이상의 임상시험기관과 파트너십을 구축한 노보텍은, 다양한 환자 집단과 주요 입상시험 대상에 대한 최적의 접근성을 제공하고 있습니다.  

노보텍은 치료 및 규제 전문성, 고객 중심 서비스 모델, 현지 시장 인사이트, 첨단 분석 기술을 바탕으로, 환자 모집을 가속화하고, 임상시험 효율성을 극대화하며, 혁신적인 치료제를 보다 신속하게 시장에 도입하는 데 기여하고 있습니다. 이러한 노보텍의 역량은 업계에서도 높은 평가를 받고 있으며, Frost & Sullivan의 ‘Global Biotech CRO Award’를 19년 연속 수상하는 등 글로벌 CRO로서의 입지를 공고히 하고 있습니다.  

더 자세한 정보나 임상시험 관련 상담이 필요하시면, 노보텍 공식 웹사이트를 (www.Novotech-CRO.com) 방문해 주시기 바랍니다.